789TiPHALO 109-301: Phase III, randomized, double-blind, placebo-controlled study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients with previously untreated hyaluronan (HA)-high stage IV pancreatic ductal adenocarcinoma (PDA). (23rd October 2018) - Van Cutsem, E; Corrie, P G; Ducreux, M P; Sigal, D; Sahai, V; Oh, D-Y; Bullock, A; Bang, Y-J; Baron, A D; Hendifar, A; Li, C-P; Philip, P; et al.